E Frei1, D Spriggs. Show Affiliations » 1. Dana-Farber Cancer Institute, Boston.
Abstract
Entities: Gene
Mesh: See more » Dose-Response Relationship, DrugDrug EvaluationHumansRecombinant Proteins/administration & dosageRecombinant Proteins/adverse effectsRecombinant Proteins/therapeutic useTumor Necrosis Factor-alpha/administration & dosageTumor Necrosis Factor-alpha/adverse effectsTumor Necrosis Factor-alpha/therapeutic use
Substances: See more » Recombinant ProteinsTumor Necrosis Factor-alpha
Year: 1989 PMID: 2645383 DOI: 10.1200/JCO.1989.7.3.291
Source DB: PubMed Journal: J Clin Oncol ISSN: 0732-183X Impact factor: 44.544